CClinicalTrials.gg
Status unknownNCT05671926Updated Jan 5, 2023

Different Algorithm Models to Predict Postoperative Pneumonia in Elderly Patients

An observational study in Postoperative Pulmonary Complications, sponsored by Wuhan Union Hospital, China. Status unknown. Open to participants aged 65 Years and older. Per ClinicalTrials.gov, last updated 2023-01-05.

Sponsored by Wuhan Union Hospital, China · Observational

The sponsor has not verified this record recently (last verified Dec 2022), so the status shown — last known as Not yet recruiting — may be out of date.
Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
10,000
Ages
65 Years and older
Sex
All
01

Study summary

The researchers aim to compare different algorithms to predict postoperative pneumonia in elderly patients and to assess the risk of pneumonia in elderly patients.

Read the detailed description

Postoperative pneumonia is a common complication that increases the mortality and length of older patients. In order to better assess the risk of postoperative pneumonia in elderly patients, we plan to use database information and different algorithms, such as logistic regression, random forest, and other algorithms respectively to build models and evaluate the effects of the models.

02

Conditions studied

  • Postoperative Pulmonary Complications

Browse trials for

03

In context

Pneumonia

2,044 studies on the registry are indexed under Pneumonia; 283 are open to participants now.

This study's planned enrollment of 10,000 is above the median of 203 across 688 observational studies indexed under Pneumonia.

Browse Pneumonia studies →

Lead sponsor

Wuhan Union Hospital, China is the lead sponsor of 230 studies on the registry; 104 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
65 Years and older
Sexes eligible
All
Sampling method
Probability sample

Study population

older patients received general anesthesia in Wuhan Union Hospital from January 1, 2014 to December 31, 2019.

Inclusion criteria

  1. Age 65 years or older
  2. receiving invasive ventilation during general anesthesia for surgery

Exclusion criteria

Exclusion Criteria:

  1. preoperative mechanical ventilation
  2. procedures related to a previous surgical complication
  3. a second operation after surgery
  4. organ transplantation
  5. discharged within 24 hours after surgery
  6. cardiac and thoracic surgery
05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
10,000 participants (estimated)
Patient registry
No

Groups and cohorts

  • Training set

    The whole cohort is randomly assigned to a training cohort and validation cohort.

  • validation set

    The whole cohort is randomly assigned to a training cohort and validation cohort.

06

What researchers measure

Primary outcomes

  1. Postoperative pulmonary complications

    Time frame: within one week after surgery

Secondary outcomes

  1. Postoperative pulmonary complications

    Time frame: 30 days after surgery

07

Study locations

No study locations are listed for this record.

08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 5, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05671926
Lead sponsor
Wuhan Union Hospital, China
Responsible party
Sponsor
First posted
Jan 5, 2023
Start date
Jan 2023 (estimated)
Primary completion
Feb 2023 (estimated)
Completion
Feb 2023 (estimated)
Last update
Jan 5, 2023

Study contacts

Qingping Wu, PhD
Contact
wqp1968@163.com
13971605283

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Dec 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion